Asia Pacific Archives - Page 2 of 9 - Journal for Clinical Studies

Current Edition

Asia Pacific

Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today announced positive top-line results for the pivotal Phase II DESTINY-Breast01 trial of trastuz...

16 May 2019 Asia Pacific | news | Regional News

Continue Reading →

Asia Pacific

Wave delays key data readout for Huntington’s therapy

Studies of two experimental Huntington's disease treatments from Wave Life Sciences aren't enrolling as fast as the company expected, implying that topline data won'...

18 April 2019 Asia Pacific | news | Regional News

Continue Reading →

Asia Pacific

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in ...

8 April 2019 Asia Pacific | news | North America | Regional News

Continue Reading →

Asia Pacific

Astellas’ AML therapy bests chemo in Phase 3 study

In a Phase 3 trial, Astellas’ Xospata improved survival for patients with relapsed or refractory acute myeloid leukemia (AML) compared to chemotherapy, according to ...

4 April 2019 Asia Pacific | news | Regional News

Continue Reading →

Asia Pacific

Forxiga approved in Japan for type-1 diabetes

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Forxiga (dapagliflozin) as an oral adjunct treatment to insulin for adults with type-1 diabet...

28 March 2019 Asia Pacific | news | Regional News

Continue Reading →

Asia Pacific

FDA Green-Lights Two Therapies, While Late-Stage Successes Set Stage for Potential Approvals

The U.S. Food and Drug Administration (FDA) has been busy approving new treatments for various diseases. Two days into the new week and the regulatory agency has gre...

13 March 2019 Asia Pacific | news | North America | Regional News

Continue Reading →

Asia Pacific

Takeda’s Entyvio beats AbbVie’s Humira in head-to-head UC study

Takeda's Entyvio outperformed AbbVie's Humira as an ulcerative colitis therapy, according a topline readout of a Phase 3b study by the Japanese pharma.The ...

13 March 2019 Asia Pacific | Europe | news | Regional News

Continue Reading →

Asia Pacific

WuXi STA and Ark Biosciences Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Ark Biosciences, a global biotech company focusing on innovative drug discovery and deve...

7 March 2019 Asia Pacific | news | Regional News

Continue Reading →

Asia Pacific

Owlstone Medical Partners with Shanghai Renji Hospital to Pioneer Breath Biopsy Lung Cancer Trial in China

Cambridge, UK, and Shanghai, China, February 20 2019: Owlstone Medical Ltd., a global diagnostics company developing a breathalyzer for applications in ea...

20 February 2019 Asia Pacific | news | Regional News

Continue Reading →

Asia Pacific

Development progress in 2018 for acute ischemic stroke drugs will fuel market growth, says GlobalData

Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*; however, novel drugs designed to...

Continue Reading →